John Hural

6.1k citations

35 papers · 1.6k indexed · 1 hit paper · h-index 18

Impact in

Virology top 1%
- HIV Research and Treatment
Immunology top 5%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology

Papers in ⓘ

Virology 20
- HIV Research and Treatment 20
Immunology 13
- Immunotherapy and Immune Responses 7
- Immune Cell Function and Interaction 6
- Mast cells and histamine 3

Co-authors: Melissa A. Brown (3 shared papers)Matthew A. Brown (1 shared paper)M. Juliana McElrath (12 shared papers)Steven G. Self (2 shared papers)Zoe Moodie (3 shared papers)Olivier Defawe (3 shared papers)Lawrence Corey (6 shared papers)Susan Buchbinder (5 shared papers)
Journals: The Journal of Infectious Diseases (5 papers)Journal of Immunological Methods (3 papers)PLoS ONE (3 papers)Scientific Reports (2 papers)JAIDS Journal of Acquired Immune Deficiency Syndromes (2 papers)
Partner nations: United States South Africa United Kingdom

In The Last Decade

John Hural

34 papers receiving 1.6k citations

Hit Papers

align trajectories log scale

HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case–cohort analysis 2008 · 517 citations

Peers

Countries citing papers authored by John Hural

Since Specialization

Citations

This map shows the geographic impact of John Hural's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Hural with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Hural more than expected).

Fields of papers citing papers by John Hural

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Hural. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Hural. The network helps show where John Hural may publish in the future.

Co-authors

The 25 scholars most cited alongside John Hural, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John Hural Line = papers co-authored together John Hural links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case–cohort analysis The Lancet ·M. Juliana McElrath, Stephen C. De Rosa, Zoe Moodie, Sheri Dubey, Lisa Kierstead, Holly Janes, Olivier Defawe, Donald K. Carter, John Hural, Rama Akondy, Susan Buchbinder, Michael Robertson, Devan V. Mehrotra, Steven G. Self, Lawrence Corey, John W. Shiver, Danilo R. Casimiro Hit paper breakdown →	2008	517
2	Functions of IL-4 and Control of Its Expression Critical Reviews in Immunology ·Melissa A. Brown, John Hural	1997	256
3	Phase 1 Safety and Immunogenicity Testing of DNA and Recombinant Modified Vaccinia Ankara Vaccines Expressing HIV-1 Virus-like Particles The Journal of Infectious Diseases ·Paul A. Goepfert, Marnie Elizaga, Alicia Sato, Qin Li, M. Cardinali, Christine M. Hay, John Hural, Stephen C. DeRosa, Olivier Defawe, Georgia D. Tomaras, David C. Montefiori, Yongxian Xu, Lilin Lai, Spyros A. Kalams, Lindsey R. Baden, Sharon E. Frey, William A. Blattner, Linda S. Wyatt, Bernard Moss, Harriet L. Robinson	2011	120
4	Safety and Immunogenicity of an HIV-1 Gag DNA Vaccine with or without IL-12 and/or IL-15 Plasmid Cytokine Adjuvant in Healthy, HIV-1 Uninfected Adults PLoS ONE ·Spyros A. Kalams, Scott Parker, Xia Jin, Marnie Elizaga, Barbara Metch, Maggie Haitian Wang, John Hural, Michael D. Lubeck, John H. Eldridge, M. Cardinali, William A. Blattner, Magda Sobieszczyk, Vinai Suriyanon, Artur Olhovetchi Kalichman, David B. Weiner, Lindsey R. Baden, (unknown)	2012	90
5	Functions of IL-4 and Control of Its Expression Critical Reviews in Immunology ·Matthew A. Brown, John Hural	2017	85
6	Nuclear Factor of Activated T Cells Is Associated with a Mast Cell Interleukin 4 Transcription Complex Molecular and Cellular Biology ·D L Weiss, John Hural, David Tara, Luika Timmerman, Greg Henkel, Melissa A. Brown	1996	67
7	A Trimeric, V2-Deleted HIV-1 Envelope Glycoprotein Vaccine Elicits Potent Neutralizing Antibodies but Limited Breadth of Neutralization in Human Volunteers The Journal of Infectious Diseases ·Paul Spearman, Michelle Lally, Marnie Elizaga, David C. Montefiori, Georgia D. Tomaras, M. Juliana McElrath, John Hural, Stephen C. De Rosa, Alicia Sato, Yunda Huang, Sharon E. Frey, Paul Sato, John Donnelly, Susan W. Barnett, Lawrence Corey, (unknown)	2011	60
8	An Intron Transcriptional Enhancer Element Regulates IL-4 Gene Locus Accessibility in Mast Cells The Journal of Immunology ·John Hural, Millie Kwan, Greg Henkel, M. Benjamin Hock, Melissa A. Brown	2000	57
9	Statistical positivity criteria for the analysis of ELISpot assay data in HIV-1 vaccine trials Journal of Immunological Methods ·Zoe Moodie, Yunda Huang, Lin Gu, John Hural, Steven G. Self	2006	50
10	Optimization of storage and shipment of cryopreserved peripheral blood mononuclear cells from HIV-infected and uninfected individuals for ELISPOT assays Journal of Immunological Methods ·Adriana Weinberg, Lin Song, Cindy Wilkening, Terry Fenton, John Hural, Raul Louzao, Guido Ferrari, Paige E. Etter, Mark Berrong, Jennifer Canniff, Donald Carter, Olivier Defawe, Ambrosia Garcia, Tania L. Garrelts, Rebecca Gelman, Linda K. Lambrecht, Savita Pahwa, Sudheesh Pilakka‐Kanthikeel, David Shugarts, Nancy B. Tustin	2010	50
11	Phase I Safety and Immunogenicity Evaluations of an Alphavirus Replicon HIV-1 Subtype CgagVaccine in Healthy HIV-1-Uninfected Adults Clinical and Vaccine Immunology ·Margaret Wecker, Peter B. Gilbert, Nina D. Russell, John Hural, Mary Allen, Michael Pensiero, Jeffrey D. Chulay, Ya-Lin Chiu, Salim S. Abdool Karim, Donald S. Burke	2012	50
12	Evaluation and Recommendations on Good Clinical Laboratory Practice Guidelines for Phase I–III Clinical Trials PLoS Medicine ·Marcella Sarzotti‐Kelsoe, Josephine H. Cox, Naana Cleland, Thomas N. Denny, John Hural, Leila K. Needham, Daniel A. Ozaki, Isaac R. Rodriguez‐Chavez, Gwynneth Stevens, Timothy A. Stiles, Tony Tarragona-Fiol, Anita Simkins	2009	34
13	Identification of Naturally Processed CD4 T Cell Epitopes from the Prostate-Specific Antigen Kallikrein 4 Using Peptide-Based In Vitro Stimulation The Journal of Immunology ·John Hural, Rachel S. Friedman, Andria L. McNabb, Sean Steen, Robert Henderson, Michael Kalos	2002	32
14	The Safety and Immunogenicity of an Interleukin-12–Enhanced Multiantigen DNA Vaccine Delivered by Electroporation for the Treatment of HIV-1 Infection JAIDS Journal of Acquired Immune Deficiency Syndromes ·Jeffrey M. Jacobson, Lu Zheng, Cara C. Wilson, Pablo Tebas, Roy M. Matining, Michael A. Egan, John H. Eldridge, Alan Landay, David B. Clifford, Anne F. Luetkemeyer, Jennifer Tiu, A. L. Sánchez Martinez, Jennifer Janik, Teresa Spitz, John Hural, M. Juliana McElrath, Nicole Frahm	2015	21
15	Calibration of two validated SARS-CoV-2 pseudovirus neutralization assays for COVID-19 vaccine evaluation Scientific Reports ·Yunda Huang, Oleg Borisov, Jia Jin Kee, Lindsay N. Carpp, Terri Wrin, Suqin Cai, Marcella Sarzotti‐Kelsoe, Charlene McDanal, Amanda Eaton, Rolando Pajón, John Hural, Christine M. Posavad, Katherine Gill, Shelly Karuna, Lawrence Corey, M. Juliana McElrath, Peter B. Gilbert, Christos J. Petropoulos, David C. Montefiori	2021	20
16	A Phase 1 Randomized, Placebo-controlled, Observer-blinded Trial to Evaluate the Safety and Immunogenicity of Inactivated Streptococcus pneumoniae Whole-cell Vaccine in Adults The Pediatric Infectious Disease Journal ·Cheryl Keech, Royce A. Morrison, Porter Anderson, Andrea Tate, Jorge Flores, David Goldblatt, David E. Briles, John Hural, Richard Malley, Mark R. Alderson	2020	19
17	Decreased Pre-existing Ad5 Capsid and Ad35 Neutralizing Antibodies Increase HIV-1 Infection Risk in the Step Trial Independent of Vaccination PLoS ONE ·Cheng Cheng, LingShu Wang, Jason G. Gall, Martha Nason, Richard Schwartz, M. Juliana McElrath, Steven C. DeRosa, John Hural, Lawrence Corey, Susan Buchbinder, Gary J. Nabel	2012	19
18	HIV-specific humoral responses benefit from stronger prime in phase Ib clinical trial Journal of Clinical Investigation ·Pierre‐Alexandre Bart, Yunda Huang, Shelly Karuna, Samuel Chappuis, Julien Gaillard, Nidhi Kochar, Xiaoying Shen, Mary Allen, S.-W Ding, John Hural, Hua-Xin Liao, Barton F. Haynes, Barney S. Graham, Peter B. Gilbert, M. Juliana McElrath, David C. Montefiori, Georgia D. Tomaras, Giuseppe Pantaleo, Nicole Frahm	2014	18
19	Preexisting Adenovirus Seropositivity Is Not Associated With Increased HIV-1 Acquisition in Three HIV-1 Vaccine Efficacy Trials The Journal of Infectious Diseases ·Kathryn E. Stephenson, John Hural, Susan Buchbinder, Faruk Sinangil, Dan H. Barouch	2012	14
20	Performance of a Redesigned HIV Selectest Enzyme-Linked Immunosorbent Assay Optimized To Minimize Vaccine-Induced Seropositivity in HIV Vaccine Trial Participants Clinical and Vaccine Immunology ·Oksana Penezina, N. Krueger, Isaac R. Rodriguez‐Chavez, Michael P. Busch, John Hural, Jérôme H. Kim, Robert J. O’Connell, Eric Hunter, Said Aboud, Keith Higgins, V. A. Kovalenko, David E. Clapham, David Crane, Andrew Levin, (unknown)	2014	13

About John Hural

John Hural is a scholar working on Virology, Immunology, Clinical Biochemistry, Infectious Diseases and Hepatology, having authored 35 papers that have together received 1.6k indexed citations. Recurring topics across this work include HIV Research and Treatment (20 papers), vaccines and immunoinformatics approaches (9 papers), Immunotherapy and Immune Responses (7 papers), Immune Cell Function and Interaction (6 papers), HIV/AIDS Research and Interventions (5 papers), Metabolism and Genetic Disorders (3 papers), Mast cells and histamine (3 papers) and Hepatitis B Virus Studies (3 papers). The work is most often cited by research in Virology (619 citations), Immunology (804 citations), Infectious Diseases (360 citations), Epidemiology (414 citations) and Immunology and Allergy (61 citations). John Hural has collaborated with scholars based in United States, South Africa and United Kingdom. Frequent co-authors include Melissa A. Brown, Matthew A. Brown, M. Juliana McElrath, Steven G. Self, Zoe Moodie, Olivier Defawe, Lawrence Corey, Susan Buchbinder, Stephen C. De Rosa and Holly Janes. Their work appears in journals such as The Journal of Infectious Diseases, Journal of Immunological Methods, PLoS ONE, Scientific Reports and JAIDS Journal of Acquired Immune Deficiency Syndromes.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact